Which company should you consider buying right now?AbbVie (NYSE: ABBV) and Merck (NYSE: MRK) currently boast the No. 1 and No. 2 best-selling drugs on the market. AbbVie's Humira, which is used to treat Crohn's disease, just grossed $20 billion in sales in 2020, while Merck's No. 2, Keytruda, did $...

https://www.fool.com/investing/2021/05/01/better-buy-for-2021-abbvie-or-merck/?source=iedfolrf0000001

#fool